Novel reactive sorbents to sorb, immobilize, and transform malodorous molecules for palliative management of malignant fungating wounds
新型反应性吸附剂可吸附、固定和转化恶臭分子,用于恶性真菌伤口的姑息治疗
基本信息
- 批准号:10337824
- 负责人:
- 金额:$ 23.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-30 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcneActivated CharcoalAdvanced Malignant NeoplasmAerobic BacteriaAffectAldehydesAlginatesAminesAnaerobic BacteriaAnxietyBenzoyl PeroxideBiopolymersCadaverineCancer PatientCarboxylic AcidsCaringCationsCharcoalChemicalsChitosanDistressEnvironmentEquilibriumEvaluationFelis catusFutureGaggingGeneral PracticesGoalsGreen teaHoneyHumanIminesImmobilizationIn VitroIodineKnowledgeLeadLife ExpectancyLonelinessMalignant - descriptorMasksMental DepressionMethodsMetronidazoleMicrobial BiofilmsOdorsOutcomeOxidesPalliative CarePatient CarePatientsPerformancePersonsPilot ProjectsPolyaminesPolymersPopulationPutrescineQuality of lifeReactionReportingSaltsSideSilverSiteSocial isolationSterile coveringsStructureSulfoxideSulfur CompoundsSymptomsTechnologyTemperatureTopical applicationUnited StatesVolatile OilsVomitingWithdrawalWorkWound modelsappetite lossbasebiomaterial compatibilitychronic woundcovalent bonddesigndisabling symptomend of lifehealingimprovedin vitro Modelnew technologynovelnovel strategiesorganic acidpalliativepreferencepsychologicpsychological distresssocialsuccesssugarsymptom managementwoundwound dressing
项目摘要
Project Summary/Abstract
Malignant fungating wounds (MFWs) affect 5% to 14% of advanced cancer patients in the United States.
Sadly, the average life expectancy for a person living with MFWs is six to twelve months. Malodor is the most
distressing and debilitating symptom of MFWs, causing gagging, vomiting, loss of appetite, and psychological
distress, including social withdrawal, social isolation, anxiety, loneliness, and depression. Malodor results from
a cocktail of volatile agents that includes acids, polyamines, and sulfur compounds such as dimethyl trisulfide
(DMTS). The current methods used to manage malodor are: (a) reducing bioburdens that cause odor, (b)
masking the odor, and (c) absorbing the odor (e.g., via charcoal, green tea teabags, cat litter, etc.). However,
these strategies offer only limited success and malodor continues to be the worst aspect of MFWs.
The goals of advanced cancer patient care should include a palliative approach for symptom management
to improve quality of life. To this end, this project will develop a novel reactive sorbent approach to sorb,
immobilize, and/or transform malodorous molecules that are generated by MFWs to improve odor
management in palliative care. This new strategy has never been reported before. We will selectively oxidize
alginate (a natural anionic polymer) to generate covalently bonded aldehyde groups for charcoal coating to
form porous amine-reactive sorbents. In this design, the charcoal will sorb polyamines (e.g., putrescine and
cadaverine) to reduce their contents, the carboxylic acid groups on the alginate will ionically immobilize the
amines through acid/base reactions, and the aldehyde groups will covalently immobilize the amines through
the formation of odorless imine structures. Also, we will use chitosan, a natural cationic polymer, to coat
benzoyl peroxide (BPO), a mild oxidizer for acne treatment, onto charcoal to form porous acid-/DMTS-reactive
sorbents. The charcoal will sorb the acids (e.g., n-butyric, n-valeric, and n-caproic) and DMTS, the chitosan
will react with the acids to form odorless salts through acid/base reaction, and the BPO will oxidize the DMTS
to transform it into sulfoxide and thiosulfinate derivatives with a much less unpleasant odor. These combined
actions are expected to improve the level of odor management significantly.
The specific aims of this project are to: (1) fabricate new reactive sorbents, (2) evaluate in vitro the odor
control performance of the new reactive sorbents, and (3) evaluate the performance of the new reactive
sorbents in a wound-like in vitro model. A unique feature of the reactive sorbents is that they will not only sorb
malodorous molecules to reduce the molecule content, but they also will react with the molecules to transform
them into non-volatile, odorless (or with a much less unpleasant odor) molecules. The reactive sorbents can be
used alone or with current odor-managing strategies for comprehensive odor management. Thus, this work will
have a major positive impact on the palliative care of end-of-life cancer patients.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YUYU SUN其他文献
YUYU SUN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YUYU SUN', 18)}}的其他基金
Novel reactive sorbents to sorb, immobilize, and transform malodorous molecules for palliative management of malignant fungating wounds
新型反应性吸附剂可吸附、固定和转化恶臭分子,用于恶性真菌伤口的姑息治疗
- 批准号:
10544741 - 财政年份:2021
- 资助金额:
$ 23.02万 - 项目类别:
Rechargeable Long-term Anticandidal Denture Materials
可充电长期抗念珠菌义齿材料
- 批准号:
8288695 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Rechargeable Long-term Anticandidal Denture Materials
可充电长期抗念珠菌义齿材料
- 批准号:
8107386 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Rechargeable Long-term Anticandidal Denture Materials
可充电长期抗念珠菌义齿材料
- 批准号:
8664245 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Rechargeable Long-term Anticandidal Denture Materials
可充电长期抗念珠菌义齿材料
- 批准号:
8464540 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Rechargeable Long-term Anticandidal Denture Materials
可充电长期抗念珠菌义齿材料
- 批准号:
8579971 - 财政年份:2011
- 资助金额:
$ 23.02万 - 项目类别:
Antibiofilm tubing to reduce occupational exposure to biohazards in dentistry
抗菌膜管可减少牙科生物危害的职业暴露
- 批准号:
7625021 - 财政年份:2008
- 资助金额:
$ 23.02万 - 项目类别:
Rechargeable Long-term Antifungal Denture Materials
可充电长期抗真菌义齿材料
- 批准号:
7360713 - 财政年份:2008
- 资助金额:
$ 23.02万 - 项目类别:
Rechargeable Long-term Antifungal Denture Materials
可充电长期抗真菌义齿材料
- 批准号:
7576132 - 财政年份:2008
- 资助金额:
$ 23.02万 - 项目类别:
Multipurpose Protective Clothes for Emergency Responders
紧急救援人员的多用途防护服
- 批准号:
7510779 - 财政年份:2007
- 资助金额:
$ 23.02万 - 项目类别:
相似海外基金
Metagenomic discovery and optimization of novel endolysins targeting Cutibacterium acnes to treat acne vulgaris
针对痤疮皮肤杆菌治疗寻常痤疮的新型内溶素的宏基因组发现和优化
- 批准号:
10821291 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
Selective CYP26 inhibitors for the oral treatment of recalcitrant nodular acne.
用于口服治疗顽固性结节性痤疮的选择性 CYP26 抑制剂。
- 批准号:
10822482 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
ENLIGHT : Light-sensitive Engineered Living Material for acne therapy
ENLIGHT:用于痤疮治疗的光敏工程活性材料
- 批准号:
EP/Y03029X/1 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
Fellowship
Developing a novel medical-grade microneedle patch to treat acne vulgaris
开发一种新型医用级微针贴片来治疗寻常痤疮
- 批准号:
10053162 - 财政年份:2023
- 资助金额:
$ 23.02万 - 项目类别:
Collaborative R&D
Smart Photodynamic Therapy for Acne by Reversibly Switchable Intersystem Crossing in Pure Organic Materials
通过纯有机材料中的可逆可切换系间交叉来治疗痤疮的智能光动力疗法
- 批准号:
10483461 - 财政年份:2022
- 资助金额:
$ 23.02万 - 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
- 批准号:
10502200 - 财政年份:2022
- 资助金额:
$ 23.02万 - 项目类别:
Th17 extracellular trap-mediated antimicrobial host defense in acne vulgaris
寻常痤疮中 Th17 细胞外陷阱介导的抗菌宿主防御
- 批准号:
10698121 - 财政年份:2022
- 资助金额:
$ 23.02万 - 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
- 批准号:
10404440 - 财政年份:2022
- 资助金额:
$ 23.02万 - 项目类别:
Acne: a disease of lipid metabolism, microbiome and the immune response
痤疮:一种脂质代谢、微生物组和免疫反应疾病
- 批准号:
10404436 - 财政年份:2022
- 资助金额:
$ 23.02万 - 项目类别:
A randomized, double-blind, multi-center comparative effectiveness study of spironolactone versus doxycycline hyclate for the treatment of acne in women
螺内酯与盐酸强力霉素治疗女性痤疮的随机、双盲、多中心比较疗效研究
- 批准号:
10296086 - 财政年份:2021
- 资助金额:
$ 23.02万 - 项目类别:














{{item.name}}会员




